ClinicalTrials.gov
ClinicalTrials.gov Menu

Colon Capsule Endoscopy Versus Standard Colonoscopy in Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00837304
Recruitment Status : Terminated
First Posted : February 5, 2009
Last Update Posted : December 10, 2012
Sponsor:
Information provided by (Responsible Party):
University Hospital Muenster

Brief Summary:

The dimension of diagnostic procedures and therapy of chronic inflammatory bowel diseases largely depends on the degree of mucosal inflammation. Video colonoscopy is currently the gold standard in the evaluation of the mucosa in patients with Ulcerative Colitis (UC). PillCam Colon Capsule was developed by Given Imaging, Israel, as possible alternative imaging modality to evaluate mucosal changes in patients with UC. The colonic mucosa can be visualized and recorded by video while the colon capsule passes the colon.

Many patients suffering from UC ask their physician for possible alternative diagnostic imaging because they are uncomfortable with conventional colonoscopy.

The primary aim of the present study is to compare the new Pillcam Colon Capsule with standard colonoscopy with respect to assessing mucosal disease activity and localization of inflamed colonic mucosa in patients with known UC.


Condition or disease Intervention/treatment
Ulcerative Colitis Device: PillCam Colon Capsule Procedure: Standard Colonoscopy

Study Type : Observational
Actual Enrollment : 14 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Colon Capsule Endoscopy Versus Standard Colonoscopy in Assessing Disease Activity in Patients With Ulcerative Colitis - A Prospective Trial
Study Start Date : January 2009
Actual Primary Completion Date : July 2012
Actual Study Completion Date : July 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
UC
Patients with known ulcerative colitis
Device: PillCam Colon Capsule
PillCam Colon Capsule: The PillCam Colon capsule has two cameras that enable the device to take video images from both ends. It is 31.11 mm in size and takes pictures at a rate of 4 frames per second. The delay mode allows recording of images from the esophagus and the stomach for 5 minutes before the capsule switches into sleep mode for 2 hours to save energy.
Procedure: Standard Colonoscopy
Standard Colonoscopy: Pts. undergo colonoscopy with a video colonoscope (CF H180 AI; Olympus, Tokyo, Japan).



Primary Outcome Measures :
  1. a) disease activity of ulcerative colitis (modified Rachmilewitz score) b) extent of colonic manifestation of ulcerative colitis c) accuracy parameters (sensitivity, specificity) [ Time Frame: 12 months ]

Secondary Outcome Measures :
  1. a) patient comfort b) detection of polyps c) differences in recognition of disease activity (physicians, nurses) d) differences in findings in the group of physicians (inter-observer differences) [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with known ulcerative colitis
Criteria

Inclusion Criteria:

  • Patients over 18 years of age with
  • known ulcerative colitis
  • Indication for Standard Colonoscopy
  • Informed Consent given by the patient

Exclusion Criteria:

  • Patient has dysphagia
  • Patient has congestive heart failure
  • Patient has renal insufficiency
  • Patient is known or is suspected to suffer from intestinal obstruction
  • Patient has a cardiac pacemaker or other implanted electronical medical devices
  • Patient is pregnant
  • Patient has had prior abdominal surgery of the GI tract
  • Patient has any condition, which precludes compliance with study and/or device instructions.
  • Age less than 18

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00837304


Locations
Germany
University of Muenster, Dept. of Medicine B
Muenster, Germany, 48149
Sponsors and Collaborators
University Hospital Muenster
Investigators
Principal Investigator: Tobias Meister, MD University of Muenster, Dept. of Medicine B

Responsible Party: University Hospital Muenster
ClinicalTrials.gov Identifier: NCT00837304     History of Changes
Other Study ID Numbers: Med-B_CCE_vs_SC
First Posted: February 5, 2009    Key Record Dates
Last Update Posted: December 10, 2012
Last Verified: February 2009

Additional relevant MeSH terms:
Colitis
Ulcer
Colitis, Ulcerative
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Colonic Diseases
Intestinal Diseases
Pathologic Processes
Inflammatory Bowel Diseases